E. Bos

Efficacy and safety of peptide receptor radionuclide therapy with [^177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma

J. Kros, C. Dirven, W. D. de Herder, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

The prevalence and severity of fatigue in meningioma patients and its association with patient-, tumor- and treatment-related factors

M. Taphoorn, J. de Bresser, L. Dirven, 2023, Neuro-oncology advances.

Cytomegalovirus infection and allospecific cytotoxic activity of graft‐infiltrating cells after heart transplantation

F. Claas, W. Weimar, A. Balk, 1994, Journal of medical virology.

Impact of maximal extent of resection on postoperative deficits, patient functioning, and survival within clinically important glioblastoma subgroups

R. Tewarie, D. Satoer, C. Dirven, 2022, Neuro-oncology.

Epidemiology of adult meningioma: Report from the Dutch Brain Tumour Registry (2000–2019)

D. Eekers, M. Anten, V. Ho, 2023, European journal of neurology.

Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial

M. Lamfers, S. Leenstra, Z. Ram, 2023, Molecular Cancer.